The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)

Shelley Hwang, E.; Hyslop, Terry; Lynch, Thomas; S. Frank, Elizabeth; Pinto, Donna; Basila, Desiree; Collyar, Deborah; V. Bennett, Antonia; P. Kaplan, Celia; M. Rosenberg, Shoshana; M. Thompson, Alastair; Weiss, Anna; H. Partridge, Ann

doi:10.1136/bmjopen-2018-026797

Public

The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)

Published in BMJ Open • Mar 1, 2019

Authors:

E. Shelley Hwang

Terry Hyslop

Thomas Lynch

Abstract

INTRODUCTION: Ductal carcinoma in situ (DCIS) is a non-invasive non-obligate precursor of invasive breast cancer. With guideline concordant care (GCC), DCIS outcomes are at least as favourable as some other early stage cancer types such as prostate cancer, for which active surveillance (AS) is a sta...

Subject

Medicine

Ductal carcinoma

Randomized controlled trial

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!